Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-16-155526

Chief Executive Officer gave up 300,444 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Anzalone Christopher Richard · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-12-13 Shares withheld for taxes : show line 1 in the form −300,444 $1.27 $381,564 816,789 D
Loading xslF345X03/doc4.xml…